Core Laboratories Inc. Form 8-K Summary
Business Context and Reporting Period
Core Laboratories Inc. (NYSE: CLB) filed a Current Report on Form 8-K dated July 29, 2026. The filing serves to disclose the company's financial results for the second quarter of 2026 and announces a quarterly cash dividend.
Key Financial Metrics and Dividend Declaration
- Dividend Declaration: A quarterly cash dividend of $0.01 per share of common stock.
- Record Date: August 10, 2026.
- Payment Date: August 31, 2026.
- Financial Results: The filing references a press release (Exhibit 99.1) containing Q2 2026 results. However, the specific text of this 8-K does not provide numerical values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes and Comparisons
The filing text does not provide specific comparative data or numerical changes versus the prior comparable period. It only confirms the issuance of the Q2 2026 results press release.
Guidance, Outlook, and Risks
The provided text contains no management commentary, forward-looking guidance, risk factors, or discussion of unusual items. The filing explicitly states that the information in the attached press release is not deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Review Exhibit 99.1 (the attached press release) for specific Q2 2026 revenue, earnings, and cash flow figures.
- Verify the dividend payment schedule (Record: Aug 10, 2026; Payable: Aug 31, 2026).
- Check for any updated full-year guidance or operational outlook in the full press release text.
- Confirm the share count to calculate total dividend payout obligations.